联环药业：控股子公司药品通过仿制药一致性评价

Core Viewpoint - The announcement indicates that the company's subsidiary, Xinxiang Changle Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the supplemental application of Estazolam tablets, which have passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1: Company Information - The approved drug, Estazolam tablets, is primarily used for treating anxiety and insomnia, and it is also indicated for tension, fear, as well as for anticonvulsant and antiepileptic purposes [1] - Estazolam is classified as a commonly used benzodiazepine sedative-hypnotic medication in clinical practice [1] Group 2: Industry Context - The approval of Estazolam tablets reflects the ongoing efforts in the pharmaceutical industry to enhance the availability of effective generic medications that meet quality and efficacy standards [1]